Allergy Therapeutics plc (AGY) Receives "Buy" Rating from Panmure Gordon

‘s stock had its “buy” rating reiterated by equities researchers at Panmure Gordon in a report issued on Tuesday, AnalystRatings.NET reports. They currently have a GBX 51 target price on the stock.